You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
Higher tumor mutational burden is linked to improved survival across multiple cancer types.
Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.
Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups
New guidelines for CYPC29 genotyping ensure that the correct alleles are tested and patients are prescribed the correct doses of common drugs
We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives
David R. Hout
Triple-negative breast cancer is not a single entity, and understanding each patient’s molecular subtype can influence treatment and outcomes
by Thermo Fisher Scientific
The move to in-house next-generation sequencing has resulted in time and tissue savings, and improved collaboration across cancer care specialties
A new detection method enhances circular RNA’s potential as a cancer biomarker and forms the basis of a new database
We sit down with England’s Chief Scientific Officer, Professor Dame Sue Hill, to learn how genomics will influence the future of pathology.
Variants in the FUT2 gene may increase susceptibility to otitis media by altering the microbiome of the middle ear
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.